Itching in kidney disease was linked to wider health burdens
A literature review connected itching with sleep problems, depressive symptoms, and other outcomes, while mortality findings were sensitive to adjustment for sleep.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
In people with chronic kidney disease, itching was associated with disturbed sleep, depressive symptoms, cardiovascular events, and higher healthcare costs. Mortality findings were less consistent, and some associations lost statistical significance after accounting for sleep. These patterns identify related health burdens; they do not show that itching causes them or that treating itching changes survival.
This abstract-based account cannot establish causation. The abstract reports how many studies found associations, but does not provide pooled effect estimates, follow-up durations, or enough detail to assess the influence of other health differences.
What the review examined
The review focused on evidence from the period before difelikefalin was approved for kidney disease–associated itching. It examined links with other health problems and survival, without reporting a comparison of treatments.
Why sleep matters
Sleep disturbance was frequently linked with itching. In some mortality studies, accounting for sleep changed whether the association met statistical significance, leaving uncertainty about how itching, sleep, and survival relate to one another.
The original publication
Association of pruritus with comorbidities and survival in chronic kidney disease: a narrative review of the pre-difelikefalin era literature.
Saucereau J, Brenaut E, Ficheux AS et al.
Ren Fail · 2026
- PubMed ID
- 41708519
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.